van der Harst P - Search Results

1

Maps of open chromatin highlight cell type-restricted patterns of regulatory sequence variation at hematological trait loci.

Paul DS, Albers CA, Rendon A, Voss K, Stephens J; HaemGen Consortium; van der Harst P, Chambers JC, Soranzo N, Ouwehand WH, Deloukas P. Paul DS, et al. Among authors: van der harst p. Genome Res. 2013 Jul;23(7):1130-41. doi: 10.1101/gr.155127.113. Epub 2013 Apr 9. Genome Res. 2013. PMID: 23570689 Free PMC article.

2

Short-term statin therapy and cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.

van der Harst P, Voors AA, van Veldhuisen DJ. van der Harst P, et al. Among authors: van veldhuisen dj. Circulation. 2004 Feb 10;109(5):e34; author reply e34. doi: 10.1161/01.CIR.0000115211.60667.A6. Circulation. 2004. PMID: 14769695 No abstract available.

3

Aggressive lipid-lowering therapy and regression of coronary atheroma.

van der Harst P, van Gilst WH, Zijlstra F. van der Harst P, et al. Among authors: van gilst wh. JAMA. 2004 Jul 7;292(1):39; author reply 39-40. doi: 10.1001/jama.292.1.39-b. JAMA. 2004. PMID: 15238583 No abstract available.

4

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

van der Harst P, Voors AA, van Veldhuisen DJ. van der Harst P, et al. Among authors: van veldhuisen dj. N Engl J Med. 2004 Aug 12;351(7):714-7; author reply 714-7. doi: 10.1056/NEJM200408123510719. N Engl J Med. 2004. PMID: 15306676 No abstract available.

5

Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins.

Asselbergs FW, van der Harst P, Jessurun GA, Tio RA, van Gilst WH. Asselbergs FW, et al. Among authors: van gilst wh, van der harst p. Vascul Pharmacol. 2005 Feb;42(3):125-40. doi: 10.1016/j.vph.2005.01.009. Vascul Pharmacol. 2005. PMID: 15792930 Review.

6

Statins and autonomic function in chronic heart failure.

van der Harst P, Voors AA, van Gilst WH, van Veldhuisen DJ. van der Harst P, et al. Among authors: van gilst wh, van veldhuisen dj. Cardiovasc Drugs Ther. 2005 May;19(3):167-8. doi: 10.1007/s10557-005-2766-z. Cardiovasc Drugs Ther. 2005. PMID: 16142591 No abstract available.

7

Vascular function and mild renal impairment in stable coronary artery disease.

van der Harst P, Smilde TD, Buikema H, Voors AA, Navis G, van Veldhuisen DJ, van Gilst WH. van der Harst P, et al. Among authors: van gilst wh, van veldhuisen dj. Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):379-84. doi: 10.1161/01.ATV.0000197844.06411.22. Epub 2005 Nov 23. Arterioscler Thromb Vasc Biol. 2006. PMID: 16306429

8

[Statins: for the time being, do not as a rule prescribe the maximum dose].

van der Harst P, Kastelein JJ, van Gilst WH. van der Harst P, et al. Among authors: van gilst wh. Ned Tijdschr Geneeskd. 2005 Nov 12;149(46):2589; author reply 2589-90. Ned Tijdschr Geneeskd. 2005. PMID: 16320673 Dutch. No abstract available.

9

Letter regarding article by Arnlov et al, "low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals".

Asselbergs FW, van der Harst P, van Gilst WH. Asselbergs FW, et al. Among authors: van gilst wh, van der harst p. Circulation. 2006 Mar 14;113(10):e406; author reply e406-7. doi: 10.1161/CIRCULATIONAHA.105.105.583252. Circulation. 2006. PMID: 16534021 No abstract available.

10

Statins in the treatment of chronic heart failure: biological and clinical considerations.

van der Harst P, Voors AA, van Gilst WH, Böhm M, van Veldhuisen DJ. van der Harst P, et al. Among authors: van gilst wh, van veldhuisen dj. Cardiovasc Res. 2006 Aug 1;71(3):443-54. doi: 10.1016/j.cardiores.2006.04.011. Epub 2006 Apr 27. Cardiovasc Res. 2006. PMID: 16730683 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

638 results

Search Page